Literature DB >> 17280583

In vivo and transgenic animal models used to study visceral hypersensitivity.

J Fioramonti1, G F Gebhart.   

Abstract

Measurement of visceral sensitivity in animals is mainly based on 'pseudoaffective' responses, which are brain stem reflexes. For example, in female, but not male rats, acute partial restraint stress induces hypersensitivity to colorectal distension. Mucosal mast cell density increases in rats after nematode infection or maternal deprivation, and both also induce colon hypersensitivity. Significantly, the proximity between nerves and mast cells has been found to be increased in adult rats submitted to maternal deprivation. Protease activation of the proteinase-activated receptor-2 also increases visceral nociception in rats, suggesting that an increase in paracellular permeability may be the primum movens in several animal models of visceral hypersensitivity. Accumulating evidence suggests that sensitization of visceral afferents is not restricted to the presumed nociceptor population, suggesting that most of the mechanosensitive afferent population can contribute to visceral discomfort and pain. Other inflammation-produced changes (e.g. subunit composition of purine-gated P2X channels) in visceral sensory neurones may also contribute to visceral hypersensitivity. This article discusses use of in vivo strategies (and transgenic mouse models) to reveal putative roles in mechanosensitivity and sensitization for molecules not previously considered to have mechanosensory functions.

Entities:  

Mesh:

Year:  2007        PMID: 17280583     DOI: 10.1111/j.1365-2982.2006.00872.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  8 in total

1.  Repeated psychological stress-induced alterations of visceral sensitivity and colonic motor functions in mice: influence of surgery and postoperative single housing on visceromotor responses.

Authors:  Muriel Larauche; Guillaume Gourcerol; Mulugeta Million; David W Adelson; Yvette Taché
Journal:  Stress       Date:  2010-07       Impact factor: 3.493

2.  Loss of visceral pain following colorectal distension in an endothelin-3 deficient mouse model of Hirschsprung's disease.

Authors:  Vladimir P Zagorodnyuk; Melinda Kyloh; Sarah Nicholas; Heshan Peiris; Simon J Brookes; Bao Nan Chen; Nick J Spencer
Journal:  J Physiol       Date:  2011-02-14       Impact factor: 5.182

3.  Development of a novel mouse constipation model.

Authors:  Chao Liang; Kai-Yue Wang; Zhi Yu; Bin Xu
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 4.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

5.  Cryptosporidium parvum isolate-dependent postinfectious jejunal hypersensitivity and mast cell accumulation in an immunocompetent rat model.

Authors:  Samira Khaldi; Gilles Gargala; Laetitia Le Goff; Simon Parey; Arnaud Francois; Jean Fioramonti; Jean-Jacques Ballet; Jean-Paul Dupont; Philippe Ducrotté; Loïc Favennec
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

6.  Anti-Inflammatory Activities of a Chinese Herbal Formula IBS-20 In Vitro and In Vivo.

Authors:  Zhonghan Yang; Viktoriya Grinchuk; Siu Po Ip; Chun-Tao Che; Harry H S Fong; Lixing Lao; Justin C Wu; Joseph J Sung; Brian Berman; Terez Shea-Donohue; Aiping Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-22       Impact factor: 2.629

Review 7.  The search for novel analgesics: targets and mechanisms.

Authors:  Tony L Yaksh; Sarah A Woller; Roshni Ramachandran; Linda S Sorkin
Journal:  F1000Prime Rep       Date:  2015-05-26

Review 8.  Identifying the Ion Channels Responsible for Signaling Gastro-Intestinal Based Pain.

Authors:  Stuart M Brierley; Patrick A Hughes; Andrea M Harrington; Grigori Y Rychkov; L Ashley Blackshaw
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.